• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Haemonetics Corp (NY: HAE )

    87.42 +0.89 (+1.03%)
    Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Haemonetics Corp

    < Previous 1 2 3 4 5 Next >
    Haemonetics Earnings Preview
    Via Benzinga
    Haemonetics Corp. (NYSE: HAE) Making Surprising Moves in Monday Session
    Via Investor Brand Network
    Haemonetics Q4 Earnings Exceed Expectations On Volume And Price Benefits
    Via Benzinga
    Recap: Haemonetics Q4 Earnings
    Via Benzinga
    Looking Into Haemonetics's Return On Capital Employed
    Via Benzinga
    Alphabet To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Wednesday
    Loop Capital boosted the price target for Alphabet Inc. (NASDAQ: GOOGL) from $120 to $125. Loop Capital analyst Rob Sanderson maintained a Buy rating. Alphabet shares fell 3.7% to $103.70 in pre-market... 
    Via Benzinga
    Incyte, Haemonetics Post Earnings Beats; One Surges Within Buy Zone
    Haemonetics stock rose within a buy zone on Tuesday, but Incyte stock toppled. 
    Via Investor's Business Daily
    Earnings Preview: Haemonetics
    Via Benzinga
    Where Haemonetics Stands With Analysts
    Via Benzinga
    9 Analysts Have This to Say About Haemonetics
    Via Benzinga
    Watch for Continued Gains in Shares of Haemonetics Corporation (HAE)
    Via Investor Brand Network
    How 2022's Biggest Healthcare Gainers Could Fare In 2023
    Health care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 2023 
    Via MarketBeat
    InMode Stock Shows Improved Technical Strength; Hits Key Technical Threshold
    The Relative Strength (RS) Rating for InMode stock moved up into a higher percentile Wednesday, as it got a lift from 64 to 78. 
    Via Investor's Business Daily
    Analysts Take Bullish Stance On Haemonetics, Cites Plasma Momentum As Catalyst
    Via Benzinga
    Haemonetics: Q2 Earnings Insights
    Haemonetics (NYSE:HAE) reported its Q2 earnings results on Monday, November 7, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Haemonetics beat estimated earnings... 
    Via Benzinga
    Expert Ratings for Haemonetics
    Over the past 3 months, 6 analysts have published their opinion on Haemonetics (NYSE:HAE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
    Via Benzinga
    Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year
    Biotech isn't the only place to make money in health care this year. 
    Via Investor's Business Daily
    Where Haemonetics Stands With Analysts
      Within the last quarter, Haemonetics (NYSE:HAE) has observed the following analyst ratings: 
    Via Benzinga
    Haemonetics: Q1 Earnings Insights
      Haemonetics (NYSE:HAE) reported its Q1 earnings results on Wednesday, August 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
      During Thursday's session, 108 stocks hit new 52-week highs. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
    Upgrades 
    Via Benzinga
    Haemonetics Stock Near Buy Zone With EPS Due
    With its next earnings report scheduled for around Aug. 10, Haemonetics stock is trading about 10% shy of a 75.44 buy point. 
    Via Investor's Business Daily
    Raymond James Thinks Haemonetics Growth Is 'Underappreciated'
    Via Benzinga
    Cutera Stock Earns Relative Strength Rating Upgrade
    On Monday, medical aesthetic Cutera stock had its Relative Strength (RS) Rating upgraded to 90 from 80 a day earlier. 
    Via Investor's Business Daily
    Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
    Via Benzinga
    Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review
    The major indexes continued to advance, despite some key warnings. 
    Via Investor's Business Daily
    Haemonetics Surges Closer To A Breakout After Squashing Quarterly Estimates, Raising Guidance
    The blood and plasma supplies provider also raised its sales guidance for the fiscal year. 
    Via Investor's Business Daily
    InMode Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
    On Tuesday, InMode stock got a positive adjustment to its Relative Strength (RS) Rating, to 86 from 72 a day earlier. 
    Via Investor's Business Daily
    ShockWave Medical Stock Scores Rising Price Performance With Jump To 92 RS Rating
    ShockWave Medical stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 81 to 92. 
    Via Investor's Business Daily
    Morgan Stanley Maintains Equal-Weight Rating for Haemonetics: Here's What You Need To Know
    Morgan Stanley has decided to maintain its Equal-Weight rating of Haemonetics (NYSE:HAE) and raise its price target from $60.00 to $70.00. Shares of Haemonetics are trading up 1.46% over the last 24... 
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.